Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.7.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.3.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.1.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
KP.3.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MA.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.81ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBL.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.28.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.61ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FR.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.2.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
FL.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GP.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
MM.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.48.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.4.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LP.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.50.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MH.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
LB.1.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JC.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDPENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20259.7China
KP.2.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LU.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LF.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KR.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used